These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 19809337)
81. Outcome of risperidone therapy in elderly patients with chronic psychosis. Sajatovic M; Ramirez LF; Vernon L; Brescan D; Simon M; Jurjus G Int J Psychiatry Med; 1996; 26(3):309-17. PubMed ID: 8976471 [TBL] [Abstract][Full Text] [Related]
82. Quetiapine-associated hypothyroidism in young female patients: a report of three cases. Poutanen O; Iso-Koivisto E; Työläjärvi M; Leinonen E Pharmacopsychiatry; 2010 Aug; 43(6):237-9. PubMed ID: 20614417 [No Abstract] [Full Text] [Related]
83. Iron deficiency in pediatric patients in long-term risperidone treatment. Calarge CA; Ziegler EE J Child Adolesc Psychopharmacol; 2013 Mar; 23(2):101-9. PubMed ID: 23480322 [TBL] [Abstract][Full Text] [Related]
84. The challenges of clinical psychopharmacological management. Howland RH J Psychosoc Nurs Ment Health Serv; 2012 May; 50(5):17-20. PubMed ID: 22533844 [TBL] [Abstract][Full Text] [Related]
85. Quetiapine and falsely elevated nortriptyline level. Schussler JM; Juenke JM; Schussler I Am J Psychiatry; 2003 Mar; 160(3):589. PubMed ID: 12611850 [No Abstract] [Full Text] [Related]
86. Quetiapine in the successful treatment of psychosis and comorbid brittle diabetes mellitus: a case report. Balter J; Mofsen R; Pinninti N Int J Psychiatry Med; 2004; 34(3):259-66. PubMed ID: 15666960 [TBL] [Abstract][Full Text] [Related]
88. Serum Ferritin, Weight Gain, Disruptive Behavior, and Extrapyramidal Symptoms in Risperidone-Treated Youth. Calarge CA; Murry DJ; Ziegler EE; Arnold LE J Child Adolesc Psychopharmacol; 2016 Jun; 26(5):471-7. PubMed ID: 26894929 [TBL] [Abstract][Full Text] [Related]
89. Antipsychotic-induced dyslipidemia treated with omega 3 fatty acid supplement in an 11-year-old psychotic child: a 1-year follow-up. Pisano S; Gritti A; Catone G; Pascotto A J Child Adolesc Psychopharmacol; 2013 Mar; 23(2):139-41. PubMed ID: 23480323 [No Abstract] [Full Text] [Related]
90. Report of a case of steroid-induced psychosis and inappropriate sexual behaviour in an adolescent. Demir T; Karacetin G; Dogangun B; Kocabasoglu N Pharmacopsychiatry; 2012 Mar; 45(2):77-9. PubMed ID: 22086740 [TBL] [Abstract][Full Text] [Related]
94. False positive urine drug screening for tricyclic antidepressants in patients taking quetiapine. Chathanchirayil SJ Aust N Z J Psychiatry; 2011 Sep; 45(9):792. PubMed ID: 21554196 [No Abstract] [Full Text] [Related]
95. Comparison of the effect of lithium plus quetiapine with lithium plus risperidone in children and adolescents with bipolar I disorder: a randomized clinical trial. Habibi N; Dodangi N; Nazeri A Med J Islam Repub Iran; 2017; 31():16. PubMed ID: 28955666 [No Abstract] [Full Text] [Related]
96. Use of risperidone in a paediatric population: an observational study. King B; Zwi K; Nunn K; Longworth J; Dossetor D J Paediatr Child Health; 2003; 39(7):523-7. PubMed ID: 12969207 [TBL] [Abstract][Full Text] [Related]
97. Cannabidiol versus risperidone for treatment of recent-onset psychosis with comorbid cannabis use: study protocol for a randomized controlled clinical trial. Rasmussen JØ; Jennum P; Linnet K; Glenthøj BY; Baandrup L BMC Psychiatry; 2021 Aug; 21(1):404. PubMed ID: 34391393 [TBL] [Abstract][Full Text] [Related]
98. Editorial: A Better Perspective on Antipsychotic-Related Hyperprolactinemia in Children and Adolescents. Strawn JR; Geracioti TD J Am Acad Child Adolesc Psychiatry; 2023 Sep; 62(9):967-969. PubMed ID: 37172820 [TBL] [Abstract][Full Text] [Related]
99. Subjective distress related to side effects and subjective well-being in first admitted adolescents with early-onset psychosis treated with atypical antipsychotics. Schimmelmann BG; Paulus S; Schacht M; Tilgner C; Schulte-Markwort M; Lambert M J Child Adolesc Psychopharmacol; 2005 Apr; 15(2):249-58. PubMed ID: 15910209 [TBL] [Abstract][Full Text] [Related]
100. Hyperprolactinaemia in first episode psychosis - A longitudinal assessment. Lally J; Ajnakina O; Stubbs B; Williams HR; Colizzi M; Carra E; Fraietta S; Gardner-Sood P; Greenwood KE; Atakan Z; Mondelli V; Ismail K; Howes O; Taylor DM; Smith S; Hopkins D; Murray RM; Gaughran F Schizophr Res; 2017 Nov; 189():117-125. PubMed ID: 28755878 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]